Apremilast 30 mg Twice Daily (BID) Combined With Dupilumab

Clinical trial NCT04306965 · COMPLETED

Trial details

NCT number: NCT04306965
Sponsor: Tufts Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2020-08-01
Primary completion: 2022-06-23
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.